Skip to main content

Table 1 Age, body weight at enrolment and treatment courses during first trimester including IPTp with SP

From: Exposure to artemether-lumefantrine (Coartem®) in first trimester pregnancy in an observational study in Zambia

Exposure group

 

AL, N=150

AL * and SP , N=9

SP and/or quinine, N=135

No anti-malarial, N=667

Unknown anti-malarial, N=40

Age group, n (%)

<20 years

20 (13.3)

1 (11.1)

14 (10.4)

118 (17.7)

7 (17.5)

20-24 years

56 (37.3)

5 (55.6)

41 (30.4)

204 (30.6)

12 (30.0)

25-29 years

35 (23.3)

2 (22.2)

44 (32.6)

199 (29.8)

12 (30.0)

30-39 years

36 (24.0)

1 (11.1)

35 (25.9)

139 (20.8)

9 (22.5)

>40 years

3 (2.0)

0 (0)

1 (0.7)

7 (1.1)

0 (0)

Body weight (kg)

Mean (± SD)

61.2 (±9.8)

60.3 (±10.1)

60.8 (±10.0)

60.3 (±10.1)

60.8 (±10.0)

Median

60.0

59.0

60.0

59.0

59.7

  1. AL = artemether-lumefantrine; SP = sulphadoxine-pyrimethamine.
  2. *AL treatment in first trimester; SP treatment in first trimester.
  3. Exposure groups represent the treatment given to the pregnant woman for the malaria episode that had occurred most recently prior to enrolment (= index episode).